Back to PE Pentwater Capital Management LP
AR2
Showing 0 of 2 quarters
Position history for PEPentwater Capital Management LP's holdings in ARRAY BIOPHARMA INC
As of its Q2 2019 13F, Pentwater Capital Management held 2,765,000 shares of AR2 (Array Biopharma), worth $128.1M. AR2 was 1.4% of Pentwater Capital Management's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.